Mobvoi Countdown to Launch, page-67

Hi Brett,

Thanks for sharing that. A good summary & lot of great information there. It’s great to see Options are in the money for holders & Directors converting & more cash in the bank for the company.

There is so much going on in CDX pipeline it honestly is hard to get your head around everything they are doing!

It’s great we will have imminent launch of the Mobvoi watch with CDX technology (FDA approved). CONNEQT also 510K pathway with FDA, so a big bonus for not only consumers but their Drs as well.

I have tried to post further information here twice this morning in relation to CDX tech in relation to clinical trials, & HC has eaten it all twice, just when I was almost done, but left the first part of my post?

Will attempt again later, feeling a bit frustrated by this.

Clinical trials & CROs also a massive market Internationally. It is what got me reading on CDX in the first place & I just wanted to share some experience from the ‘coal face’ on International clinical trial sites & why I also think CDX technology will be so helpful in both data collection, clinical utility & safety for patients between trial visits in investigational new drugs (INDs). 2 Big Pharmas already using CDX FDA approved devices in high risk patients, so the more validation for us for CRO (Contract Research Organisation’s) uptake on devices.

Of course now, my eyes are wide open to the much BIGGER picture in CDX pipeline! So glad I came across this stock when I did.

GLTAH & thanks again for all the sharing of information